In a study published in the journal Clinical Infectious Diseases a newly developed bacteriophage was used to clear a patient’s rare multi-drug resistant infection. The bacteriophage was developed by Denmark’s biotech company SNIPR Biome. Scientists developed the bacteriophage using CRISPR to selectively target Escherichia coli. The phage was used to treat a 65-year old man…
Read More